Back to Results
First PageMeta Content



Informationsschreiben - Marktrücknahme von MabCampath® (Alemtuzumab)
Add to Reading List

Document Date: 2013-10-24 18:08:19


Open Document

File Size: 111,07 KB

Share Result on Facebook